NMS Overview
This topic tells you about the New
medicine service (NMS) support that is available in Pharmacy Manager.
The New Medicine Service (NMS) is the fourth Advanced Service to be added to the NHS community pharmacy contract in England; it commenced on 1st October 2011.
This new service aims to improve medication compliance/adherence amongst patients with long-term conditions in order to maximize the benefits of the medicines prescribed, it is initially focused on particular patient groups and conditions.
Community Pharmacy England (PSNC) and NHS Employers envisage that the successful implementation of NMS will:
-
improve patient adherence which will generally lead to better health outcomes
-
increase patient engagement with their condition and medicines, supporting patients in making decisions about their treatment and self- management
-
reduce medicines wastage
-
reduce hospital admissions due to adverse events from medicines
-
lead to increased Yellow Card reporting of adverse reactions to medicines by pharmacists and patients, thereby supporting improved pharmacovigilance
-
receive positive assessment from patients
-
improve the evidence base on the effectiveness of the service
-
support the development of outcome and/or quality measures for community pharmacy.